SMMT — Put-Selling Research

by ThetaLoop Research
Skip to content
← Back to search
Last close:
Summit Therapeutics Inc.
Healthcare · $14.01
6.9
/10
Favorable Entry
↑ +2.7 today
Put-selling entry timing — not a quality rating.A high score reflects today's options setup, not a buy signal.
Surface indicators and our internal signals diverge — the score reflects the combined read.
How this score works → Try the calculator ↓
Regime
Bearish
vs SMA200
SMA200 Distance
-22.9%
Below trend
Volatility
Normal
Average premiums
Momentum
Turning
2nd day
About Summit Therapeutics Inc.
Summit Therapeutics develops ivonescimab, a bispecific antibody targeting lung cancer. No dividend, high beta, binary Phase 3 catalysts and FDA decision risk. Rich CSP premiums but trial readouts create extreme gap potential. Size positions conservatively and respect event dates.
Biotechnology
Market Cap
$10.9B
P/E Ratio
Beta
-1.31
Forward P/E
-11.8
52-Week Range Current: $14.01
$12.55 $30.98
Price Action
Bullish Engulfing
Bullish reversal pattern detected on recent candles

SMMT — premium runs richer near the 52-week floor (8th percentile) because assignment probability runs higher there too. The yield compensates for the directional exposure that justifies it, not for skill.

Based on end-of-day market dataScored by ThetaLoop Research
SMMT ranks #2 of 66 Healthcare tickers by put-selling score (622 total screened)

Position Size & Yield Calculator

Live model for SMMT — drag any slider to recalculate. Strike defaults to ~5% OTM, snapped to typical exchange increments.
$
$
$
days
0
max fully-secured contracts
Capital per Contract0%
$0
Premium Income
$0
per contract
Per-Day Theta
$0.00
if held to expiration
Annualized ROC
0.0%
return on collateral
📈At this pace: $0/year per contract if you roll continuously every 30 days
Calculator assumptions

Cash-secured puts require holding cash equal to strike × 100 shares as collateral. Strike defaults to ~5% OTM, snapped to typical exchange increments. Premium defaults to ~2% of strike — adjust to your real expected fill. Annualized ROC = (premium ÷ collateral) × (365 ÷ DTE). CSP risk is single-name concentration: experienced put-sellers typically diversify across 4–6 underlyings rather than committing the whole account to one ticker. Continuous-rolling projections assume capital can be re-deployed after each expiration and that comparable premiums remain available — actual results vary with market conditions, assignments, and rolls.

This page is the research tool — you search any ticker, get the score, configure your own setup. The daily research publishes setups that pass the nightly filters, with strike, expiry, profit-capture references, and a tracking framework. Not every ticker, not every day. Quiet days are quiet. See a sample · how the pipeline works
More Healthcare Research
APT Alpha Pro Tech, Ltd. 7.9 BMY Bristol-Myers Squibb Company 6.8 NVAX Novavax, Inc. 5.6 SRPT Sarepta Therapeutics, Inc. 4.9 ALT Altimmune, Inc. 4.6 Browse all Healthcare tickers →
📌 Embed this score on your blog
The SMMT X-Ray score updates daily after market close. Embed it on any site, blog, or trading journal — completely free, no API key needed. The visible attribution line below the widget links back to ThetaLoop and helps the project grow.
<iframe src="https://thetaloop.app/widget/xray/SMMT" width="400" height="460" frameborder="0" loading="lazy"></iframe> <p style="text-align:center;font-size:11px;margin-top:6px;font-family:sans-serif"><a href="https://thetaloop.app/xray/SMMT">SMMT X-Ray Score</a> by ThetaLoop</p>
Live preview: Open widget in new tab →
When setups pass our filters, see the full research format. See how daily research works →
📊 Full Research Track Record — All Wins AND Losses
Cash-Secured Puts ↗ · See a sample →